Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus
Hao Li, Yang-Xin Fu, Qi Wu, Yong Zhou, David K. Crossman, PingAr Yang, Jun Li, Bao Luo, Laurence M. Morel, Janusz H. Kabarowski, Hideo Yagita, Carl F. Ware, Hui-Chen Hsu, John D. Mountz
Hao Li, Yang-Xin Fu, Qi Wu, Yong Zhou, David K. Crossman, PingAr Yang, Jun Li, Bao Luo, Laurence M. Morel, Janusz H. Kabarowski, Hideo Yagita, Carl F. Ware, Hui-Chen Hsu, John D. Mountz
View: Text | PDF
Research Article Autoimmunity Immunology

Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus

  • Text
  • PDF
Abstract

Systemic lupus erythematosus (SLE) is a severe autoimmune disease that is associated with increased circulating apoptotic cell autoantigens (AC-Ags) as well as increased type I IFN signaling. Here, we describe a pathogenic mechanism in which follicular translocation of marginal zone (MZ) B cells in the spleens of BXD2 lupus mice disrupts marginal zone macrophages (MZMs), which normally clear AC debris and prevent follicular entry of AC-Ags. Phagocytosis of ACs by splenic MZMs required the megakaryoblastic leukemia 1 (MKL1) transcriptional coactivator–mediated mechanosensing pathway, which was maintained by MZ B cells through expression of membrane lymphotoxin-α1β2 (mLT). Specifically, type I IFN–induced follicular shuttling of mLT-expressing MZ B cells disengaged interactions between these MZ B cells and LTβ receptor–expressing MZMs, thereby downregulating MKL1 in MZMs. Loss of MKL1 expression in MZMs led to defective F-actin polymerization, inability to clear ACs, and, eventually, MZM dissipation. Aggregation of plasmacytoid DCs in the splenic perifollicular region, follicular translocation of MZ B cells, and loss of MKL1 and MZMs were also observed in an additional murine lupus model and in the spleens of patients with SLE. Collectively, the results suggest that lupus might be interrupted by strategies that maintain or enhance mechanosensing signaling in the MZM barrier to prevent follicular entry of AC-Ags.

Authors

Hao Li, Yang-Xin Fu, Qi Wu, Yong Zhou, David K. Crossman, PingAr Yang, Jun Li, Bao Luo, Laurence M. Morel, Janusz H. Kabarowski, Hideo Yagita, Carl F. Ware, Hui-Chen Hsu, John D. Mountz

×

Figure 6

Deficiency of MKL1 is associated with defective F-actin polymerization and reduced AC clearance of MZMs.

Options: View larger image (or click on image) Download as PowerPoint
Deficiency of MKL1 is associated with defective F-actin polymerization a...
(A) Representative fluorescence photomicrographs (top) and ImageJ 3D intensity plots (bottom) of splenic MARCO+ MZMs in 8-month-old mice (original magnification, ×4). Maximal and minimal intensity scales set for the plots are shown on the left. (B–D) Spleens of B6 and B6-Mkl1–/– mice were analyzed for (B) MKL1 and F-actin polymerization (phalloidin+) in FACS-sorted MZMs, (C) frequency of F4/80negCD11bloSIGN-R1+I-Ab– MZMs (red boxed areas), and (D) quantitation of total MZM cells. (E) Representative ImageStream photomicrographs of MKL1 expression and F-actin polymerization in splenic MZMs (CD11bloSIGN-R1+F4/80neg) from recipient B6-Rag1–/– mice. (F) Confocal microscopic images of AC clearance in the indicated mouse spleens following transfer of CFSE-labeled ACs (green) at the indicated times. Original magnification, ×20; digitally magnified views of the boxed areas are shown on the right. (G) FACS analysis of in vitro CFSE+ AC uptake by BM-derived macrophages 30 minutes after incubation with ACs. (H) FACS analysis of the effects of CCG-100602 on uptake of CFSE+ ACs by BM-derived macrophages from B6 mice. Bar graph shows the percentage of macrophages that were positive for CFSE+ ACs. Data represent the mean ± SEM. Results are from 3 to 5 randomly chosen follicles (A) or 20 randomly chosen cells (B) (n = 4–6; *P < 0.05, #P < 0.01, and §P < 0.005, compared with results from age-matched B6 mice, PBS-treated controls, or between the indicated groups, Student’s t test).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts